100 results about "Prevalent Nephrotic Syndrome" patented technology

The Yishenkangshuai pill for treating chronic nephrosis and renal failure incompetence is prepared with over 30 kinds of Chinese medicinal materials, including rhubarb, cooked aconite root, red ginseng, white ginseng, achyranthes root, etc. and through sorting material, washing, crushing, decocting, making pill, sterilizing and other steps. The present invention has the functions of benefiting kidney, nourishing essence, invigorating spleen, promoting diuresis, promoting blood circulation, detoxicating, etc. and is sued in treating failure incompetence, chronic nephritis, nephrosis syndromes and other nephrosis.

The present invention discloses one kind of Chinese medicine for treating uremia as well as nephropathy syndrome and renal atrophy. The Chinese medicine is prepared with 50 kinds of Chinese medicinal materials, including coix seed, licorice, tree peony bark, ledebouriella root, shunk bugbane, etc. It can activate kidney tissue, stretch kidney and improve and restore kidney function to cure the said diseases radically.

The invention provides a kit for detecting a serum anti-Annexin A2-IgG antibody. The detection kit of the invention adopts a target antigen Annexin A2 corresponding to an anti-Annexin A2-IgG antibodyof a primary nephrotic syndrome-related biomarker, uses human anti-tag peptide IgG as a standard substance for quantitative detection, and utilizes a biotin-labeled detection antibody and an enzyme-labeled streptavidin amplification system, thereby improving the accuracy and sensitivity of serum anti-Annexin A2-IgG antibody detection, and providing a better detection method for the diagnosis and treatment of primary nephrotic syndrome with the anti-Annexin A2-IgG antibody.

The present invention is concerned with aryl- / heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes of formula Iwherein R1, R2 and R3 are as described herein. The invention further provides methods for the manufacture of such compounds and pharmaceutical compositions containing them. The compounds according to the invention act as V1 a receptor modulators, and in particular as V1 a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful as therapeutics acting peripherally and centrally in the conditions of dysmenorrhea, male or female sexual dysfunction, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, anxiety, depressive disorders, obsessive compulsive disorder, autistic spectrum disorders, schizophrenia, and aggressive behavior.

The Chinese medicine for curing chronic nephritis and nephrotic syndrome, specially for curing side effect resulted from application of hormone and rebound phenomenon produced after hormone extenuation and medicine withdrawal with good therapeutic effect is a water-paste pill made up by using 8 Chinese medicinal matterials of lonicera stem and leaf, astragalus root, flowery knotweed, dioscorea root, pseudotellaria root, licorice, placenta powder and rhubarb as raw material. Its therapeutic effect is reliable, and its effective rate is above 95%, and it has no toxic side effect.

The present invention relates to a Chinese medicine oral liquor for curing nephroses with obvious therapeutic effect and high cure rate. Said Chinese medicine oral liquor is made up by using 22 Chinese medicinal materials of coptis root, scutellaria root, astragalus root, phellodendron bark, rhubarb, cooked rehmannia root and others through a certain preparation process.

The Chinese medicine preparation for treating nephritis and nephrosis syndrome includes the following four kinds of active Chinese medicine components: the component for invigorating spleen and benefiting Qi, the component for promoting blood circulation to disperse blood clots, the component for clearing away heat and promoting urination, and the component for dispelling wetness and benefiting kidney. It has the functions of the components, and is used in treating chronic nephritis, pyelonephritis and nephrosis syndrome. Clinical application shows the Chinese medicine preparation is safe and has total effective rate up to 88.6 % and no toxic side effect.

The present invention relates to method of treating a patient with a condition involving increased vascular permeability or increased angiogenesis comprising administering to the patient a therapeutically effective amount of PEDF, PEDF 44 AA peptide, a homolog of the PEDF 44 AA peptide, a homolog of the PEDF 44 AA peptide wherein amino acid residues glutamateat the (101) amino acid position, isoleucine at the (103) amino acid position, leucine at the (112) and serine at the (115) amino acid position are unchanged, or an agent that activates the PEDF receptor. Conditions for treatment include, but are not limited to, sepsis acute respiratory distress syndrome, nephrotic syndrome, diabetic neuropathy, preproliferative diabetic retinopathy, cancer or proliferative diabetic retinopathy.

The invention relates to a Chinese medicinal combination for treating nephritis, which is prepared from the following raw materials (by weight portions)through the steps of water extracting, concentrating and drying: phellodendron bark 1-5, cortex acanthopanacis 1-5, mulberry bark 2-6, ginger peel 2-6, poria peel 2-6, areca catecha 1-5 and dried orange peel 2-6.

The invention discloses a traditional Chinese medicine composition for treating nephritic syndrome, which comprises the following components in parts by weight: 10-30 parts of common achyranthes herb, 5-15 parts of houttuynia, 5-15 parts of barbed skullcap herb, 5-15 parts of motherwort, 5-15 parts of plantain herb, 10-30 parts of cogongrass rhizome, 0.5-1.5 parts of juncus communis, 2-15 parts of forsythia, 4-12 parts of rhizoma alismatis, 1-3 parts of herba elephantopi, 5-15 parts of raw milk vetch, 5-15 parts of radix rehmanniae, 5-15 parts of radix adenophorae, 5-15 parts of prunella vulgaris, 5-15 parts of ramulus euonymi, 2-6 parts of atractylodes rhizome, 2-6 parts of phellodendron bark, 4-12 parts of honeysuckle, 4-12 parts of eclipta, 4-12 parts of cortex dictamni radicis, 1-3 parts of cicada slough, 2-6 parts of fried gardenia, 2-6 parts of fried scutellaria, 2-6 parts of grifola, 2-6 parts of poria, 1-3 parts of ginger peel, 1-3 parts of radix sileris, 1-3 parts of licorice root, 4-12 parts of rhizoma anemarrhenae, 4-12 parts of skunk bugbane and 4-12 parts of bupleurum. The traditional Chinese medicine composition disclosed by the invention has the functions of nourishing the lung, spleen and kidney yang, treating tri-jiao syndrome and promoting blood circulation, can not cause injury and pain to human bodies, and has the advantages of wide medicinal resources and no toxic side effects.

The invention discloses a method for preparing a Chinese Angelica capsule, comprisingRehmannia (Cooked), Giant Typhonium Rhizome, Cassia Bark, Common Yan Rhizome, Cherry Fruit, South Dodder Seed, Buckhom Glue, Fructus Lycii, Chinese Angelica Root, and Cortex Eucommiae. Its advantage lies in that it is a pure traditional Chinese medicine prepared of raw medicinal materials by repeated purification by modern biological medicinal engineering technology on the basis of Chinese Angelica pills recorded in the JingYue Pandect. It has characters of wide curing range, no toxicity and side effect, not producing resistance to drugs, hihg cure rate, and long-term curative effect. And large numbers of clinic applications prove it has remarkable curative effect on asynodia, spermatorrhea, chronic nephritis, nephropathy syndrome, osteoporosis, osteoproliferation, climacteric syndrome of women, sterility, anaemia, frequent micturition, postpartum hemorrhage, etc.

The invention relates to a medicament (water-and-soil interdependent capsule) for treating nephropathy, characterized by comprising the following raw materials: 20-50g of white ginseng, 50-200g of codonopsis pilosula, 50-200g of fructus corni, 50-150g of schisandra, 30-50g of white atractylodes, 0-150g of yam, 50-150g of Tuckahoe, 50-100g of radix rehmanniae preparata, 50-150g of medlar, 50-100g of knotgrass, 20-50g of herba dianthi, 20-50g of red sage root, 50-150g of dandelion, 20-50g of faxia and 15-30g of dried tangerine. The medicament has very remarkable healing efficacy on latent glomerulonephritis, renal failure, uremia, long-term urokinase protein and nephropathy syndromes.

The invention discloses coarse grain total-nutrient formula food for nephritic patients and relates to the field of healthcare food. The coarse grain total-nutrient formula food is prepared from the following components by mixing: whey protein, sweet potato starch, corn starch, wheat bran, traditional Chinese medicine powder, vitamin C, calcium gluconate, magnesium oxide, zinc gluconate, stevioside and edible essence. High-quality protein, fortification vitamin and trace elements are adopted in the food, and the traditional Chinese medicine powder is added to not only supplement a large amount of high-quality protein for the nephritic patients, and the traditional Chinese medicine powder, the fortification trace elements and the basic nutrition elements generate a synergistic effect according to the proportion of the food disclosed by the invention, thereby having good auxiliary curative effects on early nephropathy, acme nephropathy, nephritic syndrome, diabetic nephropathy, and the like, and the coarse grain total-nutrient formula food is suitable for early nephritic patients and people with potential nephropathy risk.

The invention relates to a traditional Chinese medicine for curing nephrosis and nephrotic syndrome and its preparing method, prepared of the Chinese medicinal herbs: Radix astragali, prepared rhizome of rehmannia, Folium Pyrrosiae, Radix Ctematidis, Chinese alpine rush, Polygonum cuspidatum, etc, cleaning, crushing and mixing them, then screening and discarding the dross and keeping the finer part, and making into powder, and also able to make into pills, tablets or capsules. Its formula is reasonable, its curative effect is reliable, its range of adaptive symptoms is wide, it is convenient to take, its preparing method is simple, and it is low cost and suitable for clinic spreading and applying.

The invention relates to a traditional Chinese medicinal composition for treating children's nephropathy which comprises the following raw materials: dried rehmannia root 12g,anemarrhena rhizome 9g, yellow-corktree bark 6g,root bark of tree peony 9g, astragalus root 15g,pseudostellaria root 9g, poria cocos wolf 12g, Chinese yam 12g and oldenlandia 15g.

The invention relates to application of traditional Chinese medicine effective components, mainly relates to application of salvianolic acid A in independent-medicine or multiple-medicine-combined nephrotic syndrome treatment, discloses application of salvianolic acid A or medicinal salt of salvianolic acid A in independent-medicine or multiple-medicine-combined nephrotic syndrome treatment, and aims at introducing salvianolic acid A to nephrotic syndrome treatment and treating the hormonal resistance type nephrotic syndrome through an independent medicine or multi-medicine combination. By introducing salvianolic acid A, the curative effect of glucocorticoid is enhanced, salvianolic acid A is beneficial to clinical reasonable application of glucocorticoid, the treatment effectiveness of glucocorticoid is improved, and hormone toxicity and hormone resistance are reduced; meanwhile, the action characteristics and molecular mechanism of salvianolic acid A are made clear, reliable foundation is provided for treating the nephrotic syndrome through salvianolic acid A, new routes are opened up for researching new treatment medicine, and certain foundation is established for development of traditional Chinese medicine of the same type.

The invention discloses a Chinese medicinal compound preparation for treating chronic nephritis and nephrotic syndromes. The technical scheme has a key point that a preparation method for the Chinese medicinal compound preparation for treating the chronic nephritis and the nephrotic syndromes comprises the following steps of: (1) selecting ginseng, astragalus, largehead atractylodes rhizome, Indian buead, epimedium, dioscorea opposita thunb, earthworm, safflower, cherokee rose fruit, gordon euryale seed and liquoric root; (2) decocting the traditional Chinese medicines in water, concentrating decoction to form syrup concentrated solution with the density of between 1.15 and 1.30; and (3) adding 95 percent of ethanol with stirring at room temperature, when the ethanol content of the integral liquid medicine reaches 60 percent, standing the liquid medicine for over 24 hours, putting supernatant in an extractor, and heating until the supernatant does not have alcohol taste to obtain the Chinese medicinal compound preparation. The Chinese medicinal compound preparation has an excellent using effect, and can treat symptoms such as the chronic nephritis, the nephrotic syndromes and the like effectively.

The invention discloses a traditional Chinese medicine for treating nephrotic syndrome, which comprises the following components in weight parts: Radix Astragali 10-12, dioscorea rhizome 8-10, dried orange peel 5-8, jujube peel 10-12, aerial parts of epimedium 3-5, roughhaired holly root 10-12, herb of ghostplant wormwood 8-10, red ginseng 2-3, Cortex moutan 10-12, red sage root 1-12, haw 10-12, Ligusticum wallichii 5-8, pseudo-ginseng 3-5, pyrrosia leaf 10-12, ludwigia octovalvis 8-10, Aster striatus 10-12 and cherokee rose-hip 10-12. The medicine is boiled into a decoction for oral administration. The traditional Chinese medicine has obvious nephrotic syndrome treatment effect with effects like kidney and Qi tonifying, blood circulation promoting, diuresis inducing, and bowel relaxing with no toxic and side effect.

The invention relates to ultrafine powder of an HMG-CoA reductase inhibitor and a preparation method of the ultrafine powder. The HMG-CoA reductase inhibitor is mainly used for heterozygous familial and non-familial hyperlipidemia and can also be used for hypercholesteremia caused by type-2 diabetes and nephrotic syndrome. The preparation method of the ultrafine powder of the HMG-CoA reductase inhibitor includes: in a homogeneous solution containing the HMG-CoA reductase inhibitor, applying ultrasonic wave of 10kHz-500kHz in frequency, of 1mW-5000W in power and 0.1mW / cm<2>-500W / cm<2> to quickly obtain HMG-CoA reductase inhibitor crystals; subjecting the HMG-CoA reductase inhibitor crystals to conventional operations such as solid collection, washing and drying to directly obtain the ultrafine powder of the HMG-CoA reductase inhibitor. The ultrafine powder prepared by the method does not contain matrix materials, has the characterisitics of large drug carrying capacity, high dissolving speed and easiness in realizing higher bioavailability, stability and safety and the like, meets needs on improving bioavailability of drug, lowering drug dosage and reducing adverse reaction and is wider in application range.

The invention discloses a pharmaceutical composition prepared by soaking the following crude drugs in parts by weight: 75-125 parts of emilia sonchifolia, 150-250 parts of typhonium giganteum engl, 150-250 parts of leopards, 75-125 parts of alangium chinense, 150-250 parts of rohdea japonica, 150-250 parts of lardizabalaceae, 150-250 parts of talinum paniculatum, 75-125 parts of rhizoma smilacis glabrae, 75-125 parts of cucubalus baccifer, 150-250 parts of dysphania ambrosioides, 125-175 parts of litsea cubeba, 150-250 parts of dipsacus asper, 150-250 parts of polygonatum sibiricum, 125-250 parts of purslane and 150-250 parts of coriaria fruits. The pharmaceutical composition is prepared by soaking a plurality of wild crude drugs according to a certain ratio, can achieve the effect of treating an internal illness by external treatment after being externally used and particularly has a favorable effect on treating functional edema caused by nephrotic syndrome.

The medicine composition for treating autoimmune diseases contains fluothiamine derivative or its salt in the amount for effective treatment and pharmaceutically acceptable supplementary material. Itis one new kind of immunoregulator with inhibition to cellular immunity and humoral immunity. It is proved that the medicine composition has obvious curative effect and low toxicity to autoimmune diseases, including rheumatic arthritis, systemic lupus erythematosus, lupous nephritis, nephropathy syndrome, ankylosing spondylitis, psoriasis and other diseases.

The invention relates to a urine analysis intelligent toilet system and a control method, characterized in that it comprises a CPU module (1), a urine analysis module (2) electrically connected to the CPU module (1), an LCD display module (3 ), a key input module (4) and a power supply module (5) for system power supply, the key input module (4) is used to transmit the user's operation information to the CPU module (1), and the urine analysis The module (2) is used for urine test data analysis and transfers the collected data to the CPU module (1), which can detect some health indicators of the human body and prevent diabetes, acute and chronic nephritis, nephrotic syndrome, urinary tract infection, It has positive screening and forecasting functions for various diseases such as stones, biliary obstruction, liver cirrhosis, and biliary lesions.

The invention discloses a traditional Chinese medicine for treatment of nephritis. The traditional Chinese medicine is prepared from tens of herbal medicines, such as Teucrium viscidum, Long Stephania Herb, Radix Hedysari, etc. The medicine has the characteristics of short treatment course and quick effectiveness. Most patients can have obvious treatment effects by taking the medicine for only one treatment course, and edema, urinary urgency, frequent urination, hard urination, hematuria and other symptoms can all be alleviated obviously. In addition, the medicine provided in the invention has a very good treatment effect on various nephritis including acute and chronic nephritis and nephrotic syndrome.

A slowly releasing piperazine ferulate preparation for treating acute or chronic glomerulus disease, nephrosis syndrome, renal failure, autoimmune nephrosis, hematopathy and cardiovascular disease contains piperazine ferulate (40-70 wt.%), auxiliary material playing the role of slow release (10-30 wt.%) and others (the rest). Said auxiliary material may be hydroxypropyl methylcellulose and / or ethylcellulose and / or polyacrylic resins and / or polyhydroxyethenes. Its advantages include long active blood concentration period (24 hr), high curative effect and low reaction.

The present invention is a kind of Chinese medicine preparation and its preparation process. The Chinese medicine preparation is prepared with patrinia as principal component and clematis root and ephedra as adjuvant components. It has the functions of clearing away heat and toxic material, dredging meridian, relieving spasm and pain, inducing diuresis to treat stranguria, removing blood stasis and promoting pus discharge. It is used in treat prostatitis, pyelonephritis, cystitis, vaginitis, cervicitis, etc. and has obvious curative effect and no toxic side effect.

The invention relates to traditional Chinese medicine composition for treatment of nephritic syndromes and chronic renal failure and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is composed of, by weight, 1-70 parts of fermented cordyceps sinensis powder and 1-60 parts of abelmoschus manihot extracts. Effective components of the traditional Chinese medicine composition are dissolved out by a reasonable extraction method, effect enhancement is realized, and bioavailability is improved. Furthermore, the traditional Chinese medicine composition has specific treatment effects on the nephritic syndromes, chronic renal failure and the like caused by various pathological types and various reasons including glomerulus diseases, secondary systemic diseases, diabetic complications and the like.

The invention relates to a traditional Chinese medicinal preparation for treating nephritis and is characterized in that the traditional Chinese medicinal preparation is prepared from the following raw materials of: by weight, pseudostellaria root, heydyotis, achyranthes bidentata bl, lily, Chinese yam, nequim, Alisma Orientalis, tortoiseshell, anemarrhena, Cortex moutan, phellodendron, cicada slough, lumbricus, muscardine silkworm, couchgrass root, broom cypress fruit, silver flower, Japanese honeysuckle stem, pseudo-ginseng, pyrrosia leaf, a pair of Gekko gecko and 200 Prednisone tablets. The traditional Chinese medicinal preparation is prepared by the following steps of: uniformly mixing the above dried Chinese herbal medicines, crushing, grinding the Prednisone tablets into a powder, mixing the Chinese herbal medicinal powders with the Prednisone powder, sieving through a sieve of 180 meshes, and packaging into capsules. The traditional Chinese medicinal preparation for treating nephritis has good efficacy of supplementing qi and nourishing yin and stimulating blood circulation to end stasis and diuresis, and has good curative effects of treating nephritis, edema of nephrotic syndrome, proteinuria and the like. At present, the traditional Chinese medicinal preparation has been used to treat a thousand of patients with nephritis and nephrotic syndrome during the recovery period. The effective rate reaches 95.2% and the cure rate reaches 90%.

The invention relates to the technical field of pure Chinese medicaments, in particular to a medicament for treating nephritic syndromes. The medicament solves the problems of the conventional medicament for treating the nephritic syndromes has side effects on the severe nephritic syndromes. The medicament for treating the nephritic syndromes is prepared from the following raw materials in part by weight: 20 to 40 parts of plantain seed, 20 to 40 parts of corn stigma, 20 to 40 parts of lalang grass rhizome, 20 to 40 parts of salix leaf, 5 to 15 parts of areca peel, and 5 to 15 parts of exocarpium citri leiocarpae. The medicament has the effects of promoting urination, eliminating venom in vivo, promoting circulation of qi, dispersing swelling and expelling toxicity, and freeing qi of internal organs so as to fulfill the aim of treating the nephritic syndrome by combining modern pharmacological research achievements according to pathogenesis of the nephritic syndrome, selecting the Chinese medicaments from natural Chinese medicinal raw materials, and reasonably mixing the Chinese medicaments in a certain proportion. The medicament can achieve the effects of treating both symptoms and root causes, and has the advantages of quick response and short course of treatment by combining oral administration, acupuncture and food regulation.

The invention discloses a traditional Chinese medicine for treating nephrotic syndrome. The traditional Chinese medicine comprises, by weight, 2 to 3 parts of red ginseng, 10 to 15 parts of wolfberry, 1 to 2 parts of epimeddium, 10 to 12 parts of poria cocos, 10 to 12 parts of plantain, 10 to 12 parts of gynostemma pentaphylla, 3 to 5 parts of pseudo-ginseng, 10 to 12 parts of red sage root, 3 to 6 parts of ligusticum wallichii, 2 to 3 parts of Stellaria yunnanensis Franch., 10 to 12 parts of lalang grass rhizome, 12 to 15 parts of fructus rosae laevigatae, 10 to 12 parts of Gorgon fruit, 10 to 12 parts of leek root and 6 to 9 parts of polyalthia root. The traditional Chinese medicine is decocted into a decoction and the decoction is taken orally. The traditional Chinese medicine has an obvious effect of treating nephrotic syndrome, has functions of tonifying kidney and qi, promoting blood circulation and inducing diuresis and has no toxic or side effect.

The invention provides a medicine for treating nephrotic syndrome. The medicine is prepared from astragalus membranaceus, herba leonuri, cicada slough, poria cocos, Chinese yam, coix seed, fructus corni, glossy privet fruit, muberry, rhizoma alismatis, radix paeoniae rubra and licorice root by means of baking and grinding into powder. The medicine is capable of shortening the course of treatment, relieving pains of patients and particularly eliminating the side effect of adrenal cortical hormone.